PixCell's powerful blood cell detection and analysis platform technology serves as a basis for additional diagnostic products related to hemostatic and immuno-based disorders.
Platelets Aggregation - Used in diagnosing and managing platelet and hemostatic disorders, in monitoring the efficacy of anti-platelet therapy, in assessing risk of bleeding and more. Platelets aggregation tests are essential in personalized medicine and in the treatment of myocardial infarction (MI). PixCell is currently developing a dedicated HemoScreen™ cartridge for platelets aggregation testing.
Immuno-Based Diagnostics - PixCell's technology can be adapted to other types of tests, which require the detection of specific cell population. Such tests include CD4+ lymphocytes, as well as tuberculosis, malaria and cancer cells.